Objectives: Ruptured abdominal aortic aneurysm (RAAA) is associated with high morbidity and mortality. We evaluated our single-center experience with management of patients with RAAA.
Methods: Data were extracted from the electronic medical record (EMR) database to identify men aged 65 to 75 years who smoked >100 cigarettes during their lifetime. Medical records were reviewed electronically to exclude patients with abdominal imaging studies within last 5 years that would have diagnosed an AAA. AAA was defined as aortic diameter of $3.0 cm. Identified AAAs were triaged following consultation with vascular surgery or with the primary care physician. The number of eligible patients, unscreened patients, comorbidities, and AAAs identified were quantified.
Results: A total of 1268 men aged 65 to 75 years (69 6 3.2 years) were screened for an AAA between May 2016 and January 2017. Among the cohort, 41.7% patients were identified to be eligible for an ultrasound scan, of which 13.0% were current smokers, 84.3% were former smokers, and 2.5% had never smoked. Of those who had never smoked, 23.1% had a positive family history for AAA (2.1% of total). In addition, 3.2% had an abdominal imaging study performed within the last 5 years that would have identified AAA. A total of 1.1% had major comorbidities such as heart and/or neurologic disease, cancer, and end-stage renal failure that would have made the screening inappropriate. Among the patient cohort eligible for the ultrasound scan, 0.6% of patients refused screening, 26.7% of patients were found to be diabetic, who may represent a subpopulation with a decreased yield of screening, and 4.7% had peripheral arterial disease, which may represent a subpopulation with an increased yield of screening. A total of 17 aneurysms (8.3%) were found, that included 14 AAAs (6.8%) and diagnosis of three incidental iliac aneurysms (1.5%). Among this subgroup of patients, 35.3% had diabetes and 5.9% had peripheral arterial disease.
Conclusions: In summary, systematic AAA screening augmented by patient calls effectively eliminates the need to screen and reduces unnecessary burden on the imaging departments, and 77% of patients "never smoked" history is the most common reason not to screen for AAA in our patient cohort.
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